News
Data from the EMBARK trial suggest patients may have functional improvements taking the gene therapy between 8 and 9 years old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback